VINCRISTINE HOSPIRA 2 mg/2 ml, solution for injection 5 bottles of 2 ml
Active ingredients: Vincristine sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 bottles of 2 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VINCRISTINE HOSPIRA 2 mg/2 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 flacon(s) en verre suremballée(s)/surpochée(s) un film plastique (Onco-Tain®) de 2 ml
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Oct 2007
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60219803CIP73795394CIP133400937953948Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULFATE DE VINCRISTINEsolution | 2 mg · 2 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.